CA2316361A1 - A method for predicting an abnormal level of clotting proteins - Google Patents

A method for predicting an abnormal level of clotting proteins Download PDF

Info

Publication number
CA2316361A1
CA2316361A1 CA002316361A CA2316361A CA2316361A1 CA 2316361 A1 CA2316361 A1 CA 2316361A1 CA 002316361 A CA002316361 A CA 002316361A CA 2316361 A CA2316361 A CA 2316361A CA 2316361 A1 CA2316361 A1 CA 2316361A1
Authority
CA
Canada
Prior art keywords
time
abnormal level
predicting
dependent measurement
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002316361A
Other languages
French (fr)
Other versions
CA2316361C (en
Inventor
Paul Braun
Thomas B. Givens
Timothy J. Fischer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2316361A1 publication Critical patent/CA2316361A1/en
Application granted granted Critical
Publication of CA2316361C publication Critical patent/CA2316361C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G01N33/4905—Determining clotting time of blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/22—Haematology
    • G01N2800/226—Thrombotic disorders, i.e. thrombo-embolism irrespective of location/organ involved, e.g. renal vein thrombosis, venous thrombosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/38—Pediatrics
    • G01N2800/385—Congenital anomalies
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems

Abstract

A method is disclosed for predicting the presence of an abnormal level of one or more proteins in the clotting cascade from at least one time-dependent measurement profile. At least one time-dependent measurement on an unknown sample (103) is performed and a respective property of the sample is measured over time so as to derive a time-dependent measurement profile (101).
A set of a plurality of predictor variables (110) are defined which sufficiently define the data of the time-dependent measurement profile (101). A model (113) is then derived that represents the relationship between the abnormality and the set of predictor variables (110). Subsequently, the model (113) is utilized to predict which protein or proteins in the clotting cascade are at an abnormal level, with the prediction (120) being a better prediction than clot time alone.
CA002316361A 1997-12-31 1998-12-30 A method for predicting an abnormal level of clotting proteins Expired - Fee Related CA2316361C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/001,647 US6321164B1 (en) 1995-06-07 1997-12-31 Method and apparatus for predicting the presence of an abnormal level of one or more proteins in the clotting cascade
US09/001,647 1997-12-31
PCT/US1998/027865 WO1999034208A1 (en) 1997-12-31 1998-12-30 A method for predicting an abnormal level of clotting proteins

Publications (2)

Publication Number Publication Date
CA2316361A1 true CA2316361A1 (en) 1999-07-08
CA2316361C CA2316361C (en) 2007-11-27

Family

ID=21697133

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002316361A Expired - Fee Related CA2316361C (en) 1997-12-31 1998-12-30 A method for predicting an abnormal level of clotting proteins

Country Status (7)

Country Link
US (2) US6321164B1 (en)
EP (1) EP1042669A4 (en)
JP (1) JP2002500360A (en)
KR (1) KR20010033817A (en)
AU (1) AU1950399A (en)
CA (1) CA2316361C (en)
WO (1) WO1999034208A1 (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6429017B1 (en) * 1999-02-04 2002-08-06 Biomerieux Method for predicting the presence of haemostatic dysfunction in a patient sample
US6321164B1 (en) 1995-06-07 2001-11-20 Akzo Nobel N.V. Method and apparatus for predicting the presence of an abnormal level of one or more proteins in the clotting cascade
US6898532B1 (en) 1995-06-07 2005-05-24 Biomerieux, Inc. Method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample
US6502040B2 (en) 1997-12-31 2002-12-31 Biomerieux, Inc. Method for presenting thrombosis and hemostasis assay data
EP1522860A1 (en) * 1999-02-04 2005-04-13 bioMérieux, Inc. A method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample
EP1147423B1 (en) * 1999-02-04 2004-11-10 bioMérieux, Inc. A method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample
US7179612B2 (en) 2000-06-09 2007-02-20 Biomerieux, Inc. Method for detecting a lipoprotein-acute phase protein complex and predicting an increased risk of system failure or mortality
US6743596B1 (en) * 2000-10-27 2004-06-01 Biomerieux, Inc. Method of determining global coagulability hemostatic potential
US6952209B2 (en) * 2001-06-27 2005-10-04 Agilent Technologies, Inc. Variable scaled graphical indicator to display dynamic data
JP2005520170A (en) * 2001-06-29 2005-07-07 バイオメリュー・インコーポレイテッド Method for predicting increased likelihood of antiphospholipid syndrome in patients
JP4231922B2 (en) * 2002-12-26 2009-03-04 独立行政法人産業技術総合研究所 Protein structure prediction system
US20050228295A1 (en) * 2004-04-01 2005-10-13 Infraredx, Inc. Method and system for dual domain discrimination of vulnerable plaque
US7537735B2 (en) * 2004-05-21 2009-05-26 Biomerieux, Inc. Aspirator systems having an aspirator tip optical level detector and methods for using the same
DE102004059055A1 (en) * 2004-12-07 2006-06-08 Dade Behring Marburg Gmbh Method for automatically determining endogenous thrombin potential
US7480593B2 (en) 2005-08-03 2009-01-20 Suresh Gopalan Methods and systems for high confidence utilization of datasets
US8548935B2 (en) * 2008-02-14 2013-10-01 Orion Diagnostica Oy Predicting a future property using reagents by measuring properties at points in time
GB2457678A (en) * 2008-02-20 2009-08-26 Orion Diagnostica Oy Method for predicting a future property
EP2259069B1 (en) * 2008-03-31 2018-09-12 Sysmex Corporation Blood coagulation analyzer and method of analyzing blood coagulation
CA2817220C (en) * 2009-11-22 2015-10-20 Azure Vault Ltd. Automatic chemical assay classification
EP2538360A1 (en) * 2011-06-16 2012-12-26 Koninklijke Philips Electronics N.V. Method of predicting a blood dilution risk value
WO2014021994A1 (en) * 2012-08-03 2014-02-06 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Method and apparatus for aiding in the diagnosis of otitis media by classifying tympanic membrane images
US11169161B2 (en) 2014-12-18 2021-11-09 Koninklijke Philips N.V. Device, system and method for determining a fibrinogen level in a blood sample
US10460237B2 (en) 2015-11-30 2019-10-29 International Business Machines Corporation Neuron-centric local learning rate for artificial neural networks to increase performance, learning rate margin, and reduce power consumption
AU2017250570A1 (en) 2016-04-15 2018-11-15 Takeda Pharmaceutical Company Limited Method and apparatus for providing a pharmacokinetic drug dosing regiment
EP3519828A4 (en) 2016-09-29 2020-06-03 Animantis, LLC Methods and apparatus for assessing immune system activity and therapeutic efficacy
EP3571504A4 (en) 2017-01-23 2020-10-28 The Administrators of the Tulane Educational Fund Apparatus, systems and methods for integrative photo- optical/mechanical test for noncontact measurement of polymerization
US10896749B2 (en) 2017-01-27 2021-01-19 Shire Human Genetic Therapies, Inc. Drug monitoring tool
JP6952668B2 (en) * 2018-09-28 2021-10-20 シスメックス株式会社 Blood coagulation analysis method, blood coagulation analyzer, program
CN111539479B (en) * 2020-04-27 2023-08-08 北京百度网讯科技有限公司 Method and device for generating sample data
JP2022062969A (en) 2020-10-09 2022-04-21 シスメックス株式会社 Blood sample analysis method, analysis device, and analysis program
CN112735535B (en) * 2021-04-01 2021-06-25 腾讯科技（深圳）有限公司 Prediction model training method, prediction model training device, data prediction method, data prediction device and storage medium

Family Cites Families (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3307392A (en) 1964-05-04 1967-03-07 Research Corp Automatic prothrombin timer apparatus and method
US3458287A (en) 1965-04-29 1969-07-29 Medical Laboratory Automation Method and means of determining endpoint times in blood clotting tests
US3658480A (en) 1970-04-13 1972-04-25 Bio Data Corp Coagulation timing apparatus, and method
US4047890A (en) 1973-11-01 1977-09-13 Bio/Data Corporation Method and apparatus for determining deficiencies in enzymatic reactors particularly clotting factor levels in blood plasmas
SU590665A1 (en) 1976-02-11 1978-01-30 Новосибирский государственный медицинский институт Method of investigating
US4040788A (en) 1976-04-05 1977-08-09 Sanford L. Simons Apparatus, instrumentation, and method for comparing samples
DE2635081C3 (en) 1976-08-04 1980-08-07 Bio/Data Corp., Willow Grove, Pa. (V.St.A.) Method and apparatus for determining blood plasma coagulation factor levels
FR2364453A1 (en) 1976-09-08 1978-04-07 Lacombe Pierre Measurement of blood plasma coagulation time - using optical density method, suitable for oxalated or citrated plasma
US4199748A (en) 1976-11-01 1980-04-22 Rush-Presbyterian-St. Luke's Medical Center Automated method and apparatus for classification of cells with application to the diagnosis of anemia
JPS5451893A (en) 1977-09-30 1979-04-24 Sankyo Co Measuring of blood coagulating time
JPS5822703B2 (en) 1978-08-30 1983-05-10 三共株式会社 Blood coagulation measurement method
US4289498A (en) 1979-01-08 1981-09-15 Ortho Diagnostics, Inc. One-stage prothrombin assay and compositions useful therein
US4766083A (en) 1982-04-04 1988-08-23 Wako Pure Chemical Industries, Ltd. Method for the photometric determination of biological agglutination
SU1076086A1 (en) 1982-12-28 1984-02-29 Всесоюзный Научно-Исследовательский И Конструкторский Институт Медицинской Лабораторной Техники Hemocoagulograph
EP0115459A3 (en) 1983-01-26 1986-11-20 University Of Medicine And Dentistry Of New Jersey Hematological prediction of sepsis and other disease states
US4705756A (en) 1983-01-26 1987-11-10 University Of Medicine And Dentistry Of New Jersey Method of determining the existence and/or the monitoring of a pathological condition in a mammal
JPS59203959A (en) 1983-05-04 1984-11-19 Toa Medical Electronics Co Ltd Measuring device for blood clotting time
JPH0695095B2 (en) 1983-11-25 1994-11-24 株式会社島津製作所 Fully automatic blood analyzer
DE3502878A1 (en) 1985-01-29 1986-07-31 Boehringer Mannheim Gmbh, 6800 Mannheim METHOD FOR DETERMINING THE FIBRINOLYTIC STATE OF PLASMA
JPS61272655A (en) 1985-05-28 1986-12-02 Iryo Kogaku Kenkyusho:Kk Quantitative discrimination method for platelet agglutination power
GB8516081D0 (en) 1985-06-25 1985-07-31 Ciba Geigy Ag Assay & purification of amyloid components
US4902630A (en) 1985-07-22 1990-02-20 Abbott Laboratories Fluorescence polarization immunoassy and reagents for measurement of c-reactive protein
US5593897A (en) 1988-04-04 1997-01-14 Northwestern University Binding of immune complexes by modified forms of C-reactive protein
DE68925899T2 (en) 1988-04-04 1996-10-02 Lawrence A Potempa BINDING IMMUNE COMPLEXES BY MODIFIED FORMS OF C-REACTIVE PROTEINS
US4965725B1 (en) 1988-04-08 1996-05-07 Neuromedical Systems Inc Neural network based automated cytological specimen classification system and method
US5156974A (en) 1988-05-27 1992-10-20 Biodata Corporation Method for determining the fibrinogen level of a blood sample
US5003065A (en) 1988-06-14 1991-03-26 Carey Merritt Compounds and process for measuring c-reactive protein
US5697369A (en) 1988-12-22 1997-12-16 Biofield Corp. Method and apparatus for disease, injury and bodily condition screening or sensing
US5055412A (en) 1989-03-21 1991-10-08 Proksch Gary J Factor sensitive reagent for testing of blood coagulation containing ellagic acid and divalent metal ions and method of making the same
US5500345A (en) 1989-04-25 1996-03-19 Iatron Laboratories, Inc. Hybridomas producing monoclonal antibodies specific for C-reactive protein and methods for detection of C-reactive protein
EP0479922A4 (en) 1989-06-27 1992-06-17 Rush-Presbyterian-St.Luke's Medical Center Monoclonal antibodies to c-reactive protein
US5051357A (en) 1989-07-14 1991-09-24 Board Of Trustees Operating Michigan State University Method and assay using inactivation of factors Va and VIIIa by activated Protein C to diagnose thrombic disease or assay for Protein C and kit therefor
WO1991001383A1 (en) 1989-07-14 1991-02-07 Michigan State University Method for diagnosing blood clotting disorders
WO1991001497A1 (en) 1989-07-20 1991-02-07 Analytical Control Systems, Inc. Improved stable coagulation controls
SU1691741A1 (en) 1989-08-25 1991-11-15 Донецкий государственный медицинский институт Method for prognostication of hemorrhagic complications secondary to traumatosis
US4998535A (en) 1989-09-05 1991-03-12 Univ. of Washington New England Medical Center Hospitals, Inc. Thrombolysis predictive instrument
US5262303A (en) 1989-10-13 1993-11-16 Trustees Of Boston University Ligand/anti-ligand assays for adherent proteins
US5646046A (en) * 1989-12-01 1997-07-08 Akzo Nobel N.V. Method and instrument for automatically performing analysis relating to thrombosis and hemostasis
IE904244A1 (en) 1989-12-01 1991-06-05 Akzo Nv Direct fibrinogen assay
US5169786A (en) 1989-12-19 1992-12-08 Ortho Diagnostic Systems, Inc. Method of determining levels of extrinsic and intrinsic clotting factors and protein c
DE69120674T2 (en) 1990-04-17 1996-11-07 Analytical Control Syst Inc COAGULATION ASSAYS AND REAGENTS
US5862304A (en) * 1990-05-21 1999-01-19 Board Of Regents, The University Of Texas System Method for predicting the future occurrence of clinically occult or non-existent medical conditions
US5218529A (en) * 1990-07-30 1993-06-08 University Of Georgia Research Foundation, Inc. Neural network system and methods for analysis of organic materials and structures using spectral data
JPH04254760A (en) 1991-01-30 1992-09-10 Eiken Chem Co Ltd Serum amyloid a reference substance and setting method thereof
US5221628A (en) 1991-03-19 1993-06-22 Northwestern University Binding of aggregated immunoglobulin or immune complexes by serum amyloid P component
RU2012877C1 (en) 1991-04-01 1994-05-15 Белорусский научно-исследовательский институт охраны материнства и детства Method of prognosticating pulmonary disorder syndrome in premature neonates
ES2094212T3 (en) 1991-08-02 1997-01-16 Grifols Grupo Sa PROCEDURE AND APPARATUS FOR THE DETERMINATION OF THE COAGULATION TIME OF BLOOD AND PLASMA.
US5716795A (en) 1991-10-04 1998-02-10 Matschiner; John T. Thrombomodulin-based coagulometric assay of the protein C system
WO1993007491A1 (en) 1991-10-04 1993-04-15 Board Of Regents Of The University Of Nebraska A soluble thrombomodulin-based one-stage assay for vitamin k-dependent coagulation-inhibiting proteins
WO1993009438A1 (en) 1991-11-04 1993-05-13 Adeza Biomedical Corporation Screening method for identifying women at increased risk for preterm delivery
JPH05180835A (en) 1991-12-27 1993-07-23 S R L:Kk Measurement of loops anti-coagulant
US5318958A (en) 1992-05-29 1994-06-07 Queen's University At Kingston Amyloid precursor protein
JP2934557B2 (en) 1992-07-10 1999-08-16 国際試薬株式会社 Blood coagulation time measuring method and apparatus
JPH0636061A (en) 1992-07-21 1994-02-10 Fujitsu Ltd Learning system of hierarchic neural network
US5388164A (en) 1992-08-19 1995-02-07 Olympus Optical Co., Ltd. Method for judging particle agglutination patterns using neural networks
JP3224607B2 (en) 1992-09-11 2001-11-05 株式会社アズウェル Method for measuring blood coagulation factor XIII activity and reagent kit for the measurement
US5369484A (en) 1992-11-09 1994-11-29 Akzo N.V. Multiple discrete analyzer test apparatus and method
US5358852A (en) 1992-12-21 1994-10-25 Eastman Kodak Company Use of calcium in immunoassay for measurement of C-reactive protein
RU2070327C1 (en) 1992-12-25 1996-12-10 Безруков Александр Васильевич Device for measurement of coagulation time
US5344754A (en) 1993-01-13 1994-09-06 Avocet Medical, Inc. Assay timed by electrical resistance change and test strip
JP2938302B2 (en) 1993-02-25 1999-08-23 国際試薬株式会社 Blood coagulation time measuring method and apparatus
JPH06249857A (en) 1993-02-26 1994-09-09 Hitachi Ltd Automatic analyzing device
RU2061953C1 (en) 1993-03-10 1996-06-10 Тюменский государственный медицинский институт МЗ РФ Method for qualitatively determining general coagulation activity of blood platelets
US5670329A (en) * 1993-05-28 1997-09-23 Cardiovascular Diagnostics, Inc. Method and analytical system for performing fibrinogen assays accurately, rapidly and simply using a rotating magnetic field
CA2168452A1 (en) 1993-08-16 1995-02-23 Timothy J. Fischer Method and instrument for automatically performing analysis relating to thrombosis and hemostasis
US5526111A (en) 1993-08-31 1996-06-11 Boehringer Mannheim Corporation Method and apparatus for calculating a coagulation characteristic of a sample of blood a blood fraction or a control
US5472852A (en) 1993-09-15 1995-12-05 Oklahoma Medical Research Foundation Assay for detection of selective Protein C inhibition by patients
US5473732A (en) 1993-11-02 1995-12-05 Chang; Hou-Mei H. Relational artificial intelligence system
US5553616A (en) * 1993-11-30 1996-09-10 Florida Institute Of Technology Determination of concentrations of biological substances using raman spectroscopy and artificial neural network discriminator
US5856114A (en) * 1994-03-21 1999-01-05 The University Of Vermont Immunologic detection of factor VA fragments in hemorrhagic and thrombotic clinical settings
DE69521470T2 (en) 1994-04-28 2002-05-16 Dade Behring Inc CALIBRATOR FOR PROTHROMBIN TIME ASSAYS
AU1287595A (en) 1994-08-26 1996-03-22 Immtech International, Inc. A mutant protein and methods and materials for making and using it
US5504011A (en) 1994-10-21 1996-04-02 International Technidyne Corporation Portable test apparatus and associated method of performing a blood coagulation test
SE9403833D0 (en) 1994-11-08 1994-11-08 Global Hemostasis Inst Mgr Ab Analysis procedure and kit
US5705395A (en) * 1994-11-14 1998-01-06 The Scripps Research Institute Method for diagnosis of thrombotic disorders
US5567596A (en) * 1994-12-29 1996-10-22 Research Foundation Of State University Of New York Rapid assay of activators and inhibitors of clotting
DE69615339T2 (en) 1995-01-10 2002-07-04 Hemker Hendrik Coenraad METHOD FOR DETECTING THE ENDOGENIC THROMBIN POTENTIAL AND THROMBIN SUBSTRATE FOR USE IN THESE METHODS
US5708591A (en) * 1995-02-14 1998-01-13 Akzo Nobel N.V. Method and apparatus for predicting the presence of congenital and acquired imbalances and therapeutic conditions
US6321164B1 (en) 1995-06-07 2001-11-20 Akzo Nobel N.V. Method and apparatus for predicting the presence of an abnormal level of one or more proteins in the clotting cascade
US5780255A (en) 1995-06-09 1998-07-14 Instrumentation Laboratory, S.P.A. Protein C pathway screening test
DE69607176T2 (en) 1995-07-21 2000-09-21 Trinity College Dublin METHOD FOR QUANTITATIVELY DETERMINING HUMAN ACUTE PHASE SERUM AMYLOID-A PROTEINS; RECOMBINANT PROTEIN; SPECIFIC ANTIBODY
US5766869A (en) 1995-11-30 1998-06-16 Ahs Hospital Corp. Factor V ratio blood test for susceptibility to thromboembolism
EP0827425B1 (en) 1996-03-22 2004-11-03 Dade Behring Inc. Combination reagent holding and test device
JPH1026621A (en) 1996-07-12 1998-01-27 Dai Ichi Pure Chem Co Ltd Immunoassay method
US5684007A (en) 1996-09-05 1997-11-04 Otsuka Pharmaceutical Co., Ltd. Methods for inhibiting cardiac fibroblast growth and cardiac fibrosis
JP3876022B2 (en) 1996-09-26 2007-01-31 生化学工業株式会社 Method for quantifying substances that affect blood clotting time
EP0841566A1 (en) 1996-11-11 1998-05-13 Pentapharm A.G. Positive control plasma for lupus anticoagulant
AU7100898A (en) 1997-04-02 1998-10-22 Brigham And Women's Hospital Means of ascertaining an individual's risk profile for atherosclerotic disease
US6010911A (en) 1997-04-30 2000-01-04 Medtronic, Inc. Apparatus for performing a heparin-independent high sensitivity platelet function evaluation technique
EP0947585B1 (en) 1998-03-19 2001-07-25 INSTRUMENTATION LABORATORY S.p.A. Improved in vitro method, kits and reagents for screening for blood coagulation defects
AU8679298A (en) * 1998-07-31 2000-02-21 Wallace E. Carroll Method and apparatus for determining anticoagulant therapy factors

Also Published As

Publication number Publication date
US6321164B1 (en) 2001-11-20
KR20010033817A (en) 2001-04-25
CA2316361C (en) 2007-11-27
WO1999034208A1 (en) 1999-07-08
US6564153B2 (en) 2003-05-13
JP2002500360A (en) 2002-01-08
US20020019706A1 (en) 2002-02-14
EP1042669A4 (en) 2004-12-08
EP1042669A1 (en) 2000-10-11
AU1950399A (en) 1999-07-19

Similar Documents

Publication Publication Date Title
CA2316361A1 (en) A method for predicting an abnormal level of clotting proteins
CA2221712A1 (en) A method and apparatus for predicting the presence of congenital and acquired imbalances and therapeutic conditions
WO2000007025A3 (en) Methods for predicting drug response, in particular igf-i
WO2002075323A3 (en) Method and system for automated immunochemistry analysis
WO2002015458A3 (en) Discovering hidden damage in machinery and predicting remaining life
WO2003102715A3 (en) Systems and methods for work list prediction
EP1292900A4 (en) Method, computer program, and system for automated real-time signal analysis for detection, quantification, and prediction of signal changes
WO2002093327A3 (en) Process unit monitoring program
ATE262178T1 (en) IDENTIFICATION AND CHARACTERIZATION OF INTERACTING MOLECULES
AU2849300A (en) Methods and assay kits for detecting mononuclear cell phenotype
CA2178096A1 (en) Surrogates for targets and improved reference panels
NO903717D0 (en) PROCEDURE FOR ANALYSIS OF AN UNDERGRADUATE TEST.
NZ505221A (en) Method with apparatus for determining the provenance of a data carrying disc
WO2005043340A3 (en) Transformer performance prediction
WO2002000933A3 (en) Screening assays for identifying modulators of the inflammatory or immune responses
MY124085A (en) Method and apparatus for automated time domain monitoring in optical networks
TWI256478B (en) System and method for classifying defects in and identifying process problems for an electrical circuit
SE9801949D0 (en) Process control
DE69927846D1 (en) METHOD FOR DETERMINING ASTHMA SUSCEPTIBILITY
CA2377528A1 (en) Method and apparatus for presenting thrombosis and hemostasis assay data
WO1998009236A3 (en) Monitoring of load situation in a service database system
SE9802537D0 (en) Method of controlling a coating process
ATE385575T1 (en) EXPERIMENTAL SETUP, ANTIBODIES AND STANDARDS FOR THE DETECTION OF OXIDIZED AND MDA-MODIFIED LOW DENSITY LIPOPROTEINS
WO2003025612A1 (en) Electric component test system and electric component test method
KR970063608A (en) Statistical process control system and its method for semiconductor equipment

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed
MKLA Lapsed

Effective date: 20101230